spending on pharmaceuticals per capita in finland was eur in a lower level than in most other eu countries to contain cost finland has also used price freezes and cuts in reference pricing was introduced and reimbursement since then is based on the reference price that is the price of the cheapest substitutable product plus a small premium coverage decisions are reviewed based on the reassessment